US EditionBlueSphere Bio Appoints Alan Korman, Ph.D. as Chief Scientific Officer
Summary by Post Register
1 Articles
1 Articles
All
Left
Center
1
Right
BlueSphere Bio Appoints Alan Korman, Ph.D. as Chief Scientific Officer
PITTSBURGH, May 16, 2025 (GLOBE NEWSWIRE) -- BlueSphere Bio, a clinical stage drug development company focused on novel T cell based therapies, today announced the appointment of Alan Korman, Ph.D., as Chief Scientific Officer. Dr. Korman brings extensive immunotherapy drug…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
